TOI
The Oncology Institute, Inc. NASDAQ Listed Jun 4, 2020$5.26
+0.19%
vs $5.25
Mkt Cap $525.9M
52w Low $2.02
91.2% of range
52w High $5.58
50d MA $4.16
200d MA $3.57
P/E (TTM)
-9.7x
EV/EBITDA
—
P/B
—
Debt/Equity
-6.6x
ROE
385.5%
P/FCF
-174.9x
RSI (14)
59.90
ATR (14)
$0.40
Beta
0.20
50d MA
$4.16
200d MA
$3.57
Avg Volume
1.9M
The Oncology Institute, Inc., an oncology company, provides medical oncology services in the United States. Its services include physician services, in-house infusion and dispensary, clinical trial services, radiation, outpatient stem cell transplants and transfusions programs, and patient support. The company also offers and manages clinical trial services, such as managing clinical trials, palliative care programs, and stem cell transplants services. It serves adult and senior cancer patients. The company operates 67 clinic locations. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
18000 Studebaker Road · Cerritos, CA 90703 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | AMC | -0.07 | -0.02 | +71.4% | 4.07 | -0.5% | -1.7% | +0.2% | +0.2% | +1.5% | -1.0% | — |
| Mar 12, 2026 | AMC | -0.08 | -0.06 | +25.0% | 2.62 | +19.8% | +8.4% | +20.1% | +5.3% | +0.3% | -1.7% | — |
| Nov 13, 2025 | AMC | -0.12 | -0.14 | -16.7% | 3.08 | +2.9% | +28.9% | -5.0% | +0.0% | -13.3% | -0.9% | — |
| Aug 13, 2025 | AMC | -0.14 | -0.14 | +0.0% | 4.10 | -2.7% | -10.5% | +2.5% | +7.4% | -5.4% | -2.1% | — |
| May 14, 2025 | AMC | — | -0.17 | — | 2.37 | +19.4% | +28.3% | -1.6% | +2.3% | -9.2% | -3.6% | — |
| Mar 24, 2025 | AMC | -0.08 | -0.14 | -75.0% | 1.24 | -1.6% | +1.6% | -4.0% | -8.3% | +2.7% | +0.0% | — |
| Nov 13, 2024 | AMC | -0.07 | -0.18 | -157.1% | 0.26 | +0.0% | -10.8% | -23.5% | -6.7% | +7.1% | -26.6% | — |
| Aug 13, 2024 | AMC | -0.10 | -0.17 | -70.0% | 0.55 | -5.9% | -18.2% | -20.4% | -3.7% | -5.2% | +22.3% | — |
| May 14, 2024 | AMC | -0.12 | -0.22 | -83.3% | 0.90 | -1.6% | -24.0% | -1.6% | -5.1% | -4.5% | -2.3% | — |
| Mar 27, 2024 | AMC | -0.11 | -0.21 | -90.9% | 1.84 | -3.3% | -14.1% | -1.3% | -1.3% | -3.2% | +0.7% | — |
| Nov 8, 2023 | AMC | -0.13 | -0.19 | -46.2% | 1.84 | +5.4% | +27.7% | +5.1% | +3.2% | -5.5% | -7.9% | — |
| Aug 8, 2023 | AMC | -0.17 | -0.19 | -11.8% | 1.01 | -9.9% | -2.0% | -10.1% | +9.0% | -11.3% | -0.3% | — |
| May 10, 2023 | AMC | -0.17 | -0.10 | +41.2% | 0.50 | +0.0% | -1.1% | +0.2% | -9.1% | -3.8% | +3.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13 | B. Riley Securities | Maintains | Buy → Buy | — | $2.62 | $3.14 | +19.8% | +8.4% | +20.1% | +5.3% | +0.3% | -1.7% |
| Mar 13 | Needham | Maintains | Buy → Buy | — | $2.62 | $3.14 | +19.8% | +8.4% | +20.1% | +5.3% | +0.3% | -1.7% |
| Mar 9 | BTIG | Maintains | Buy → Buy | — | $2.78 | $2.70 | -2.9% | -1.8% | -4.4% | +5.7% | -5.1% | +8.4% |
| Mar 9 | Needham | Maintains | Buy → Buy | — | $2.78 | $2.70 | -2.9% | -1.8% | -4.4% | +5.7% | -5.1% | +8.4% |
| Oct 21 | BTIG | Maintains | Buy → Buy | — | $4.24 | $4.19 | -1.2% | +0.5% | +3.1% | +5.0% | +3.0% | -2.9% |
| Jun 16 | Guggenheim | Maintains | Buy → Buy | — | $0.61 | $0.63 | +4.1% | +2.8% | -3.7% | +0.4% | -10.5% | +3.8% |
| Mar 20 | Guggenheim | Maintains | Neutral → Neutral | — | $0.48 | $0.50 | +3.5% | +6.0% | +31.4% | +22.4% | -1.7% | -10.7% |
| Nov 11 | Guggenheim | Maintains | Buy → Buy | — | $2.94 | $2.91 | -1.0% | -26.2% | -3.7% | -2.4% | -2.9% | -5.6% |
| Aug 15 | Jefferies | Maintains | Buy → Buy | — | $6.51 | $6.08 | -6.6% | -4.9% | +9.2% | +0.9% | +2.6% | -4.3% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | Podnos YaleOff | Chief Medical Officer | Sell | 23,451 | $5.38 | $126K | 259,527 | -5.65% | -1.54% |
| Jun 4, 2026 | Chernett Jorey10% | — | Buy | 12,000 | $4.75 | $57K | 10,579,858 | +4.11% | +3.51% |
| May 20, 2026 | Chernett Jorey10% | — | Buy | 33,500 | $4.07 | $136K | 10,567,858 | +2.68% | -0.42% |
| May 19, 2026 | Chernett Jorey10% | — | Buy | 5,000 | $4.05 | $20K | 10,534,358 | +2.68% | -0.42% |
| May 19, 2026 | Chernett Jorey10% | — | Buy | 30,000 | $4.09 | $123K | 10,529,358 | +6.43% | +2.17% |
8-K
The Oncology Institute, Inc. -- 8-K Filing
Jun 18
8-K
Unknown — 8-K Filing
TOI's full-year 2025 results and 2026 guidance will reveal whether its value-based oncology model is generating sustainable growth and profitability, directly impacting revenue trajectory and investor confidence.
Mar 12
8-K · 5.02
!!! Very High
The Oncology Institute, Inc. -- 8-K 5.02: Executive Change
The Oncology Institute appointed Ms. Tzoumakas as a director effective February 23, 2026, expanding its board composition.
Feb 23
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Capital Management Llc | 3,476,781 | $11M | New | Mar 2026 |
| 2 | Deerfield Management Company, L.p. | 3,360,052 | $10M | — | Mar 2026 |
| 3 | Kanen Wealth Management Llc | 2,777,858 | $9M | New | Mar 2026 |
| 4 | Wexford Capital Lp | 1,711,323 | $5M | Added | Mar 2026 |
| 5 | Jane Street Group, Llc | 803,315 | $3M | Added | Dec 2025 |
| 6 | Renaissance Technologies Llc | 902,809 | $3M | Added | Mar 2026 |
| 7 | Vanguard Portfolio Management Llc | 862,839 | $3M | New | Mar 2026 |
| 8 | Ensign Peak Advisors, Inc | 626,852 | $2M | New | Mar 2026 |
| 9 | Citadel Advisors Llc | 608,267 | $2M | New | Mar 2026 |
| 10 | Ubs Group Ag | 574,652 | $2M | Added | Mar 2026 |
| 11 | Northern Trust Corp | 558,455 | $2M | Added | Mar 2026 |
| 12 | Morgan Stanley | 444,106 | $2M | Added | Dec 2025 |
| 13 | Dauntless Investment Group, Llc | 462,057 | $1M | New | Mar 2026 |
| 14 | Arrowstreet Capital, Limited Partnership | 419,423 | $1M | Added | Mar 2026 |
| 15 | Marshall Wace, Llp | 342,265 | $1M | Added | Mar 2026 |
| 16 | Jpmorgan Chase & Co | 370,177 | $1M | Reduced | Mar 2026 |
| 17 | Two Sigma Investments, Lp | 307,754 | $945K | Added | Mar 2026 |
| 18 | Mount Lucas Management Lp | 250,000 | $768K | — | Mar 2026 |
| 19 | Centiva Capital, Lp | 224,245 | $688K | New | Mar 2026 |
| 20 | Bank Of New York Mellon Corp | 162,442 | $499K | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$525.9M
Enterprise Value
$4.90B
P/E (TTM)
-9.74x
Forward P/E
—
PEG Ratio
2.27x
P/B
—
P/S
9.67x
P/FCF
-174.89x
EV/EBITDA
—
Shares Out
923.9M
Financials (TTM)
Revenue
$502.7M
Net Income
-$60.6M
EBITDA
-$29.1M
Free Cash Flow
-$27.8M
Op Cash Flow
-$24.6M
EPS Basic
$-0.54
EPS Diluted
$-0.54
EPS Forward
$-0.22
Gross Margin
13.8%
Op Margin
-7.2%
Net Margin
-12.1%
Balance Sheet
Total Assets
$164.7M
Total Liab.
$180.4M
Total Equity
-$15.7M
Cash
$33.6M
LT Debt
$77.4M
Book Value/Sh
$-0.02
Debt/Equity
-6.60x
Current Ratio
1.59
Quick Ratio
1.35
Returns & Growth
ROE
385.5%
ROA
-36.8%
ROIC
-35.7%
Rev Growth YoY
+27.8%
EPS Growth YoY
+23.9%
Price Returns
2W
+16.1%
1M
+21.5%
3M
+62.3%
6M
+49.4%
12M
+47.0%
Technicals
52W High
$5.58
52W Low
$2.02
50d MA
$4.16
200d MA
$3.57
RSI (14)
59.90
ATR (14)
$0.40
Beta
0.20
Avg Volume
1.9M
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$5.00
High
$5.00
Low
$5.00
Median
$5.00
Data updated apr 27, 2026 5:15am
· Source: financialmodelingprep.com